Welcome to the Janssen Scientific Affairs, LLC Online Complaint Reporting website for the United States. The information you provide will only be used by Janssen Scientific Affairs, LLC, our affiliates, and our service providers, to fulfill Health Authority reporting requirements. Our Privacy Policy ...
Search Janssen Science™...Search Watch An Overview of Janssen Science™ A Professional Online Scientific Knowledge Exchange Resource Healthcare Professional Chat Live For Selected Products Search Medical Information Connect With my Medical Science Liaison ...
Search Janssen Science™...Search Watch An Overview of Janssen Science™ A Professional Online Scientific Knowledge Exchange Resource Healthcare Professional Chat Live For Selected Products Search Medical Information Connect With my Medical Science Liaison ...
Search Janssen Science™...Search Watch An Overview of Janssen Science™ A Professional Online Scientific Knowledge Exchange Resource Healthcare Professional Chat Live For Selected Products Search Medical Information Connect With my Medical Science Liaison ...
Search Janssen Science™...Search Watch An Overview of Janssen Science™ A Professional Online Scientific Knowledge Exchange Resource Healthcare Professional Chat Live For Selected Products Search Medical Information Connect With my Medical Science Liaison ...
Janssen Scientific Affairs Lisa Shea is the Scientific Patient Engagement Leader for Janssen Scientific Affairs. Lisa is responsible for bringing the patient perspective in-house and leveraging it to drive high priority patient-centered activities from the earliest stages of strategy development to final ...
Janssen Research & Development, LLC Oct 04, 2023 LEADERSHIP DE&I In Action Neeta Tandon Vice President Value & Evidence Scientific Engagement Janssen Scientific Affairs, LLC. Sep 18, 2023 ONCOLOGY Sexual and Gender Minority Health Equity in Prostate Cancer Care Mark Wildgust, Ph.D. (...
Janssen Research & Development, LLC; Janssen Biotech, Inc.; and Janssen Scientific Affairs, LLC are part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Cautions Concerning Forward-Looking St...
“The phase 2 GRIFFIN study showed important results with the investigational Darzalex quadruplet regimen in the treatment of newly diagnosed, transplant-eligible multiple myeloma,” Imran Khan, MD, PhD, US vice president of Medical Affairs and Hematology at Janssen Scientific Affairs, LLC, said ...